At Vivacitas Oncology, scientific discovery and patient-focused thinking drive our pursuit of new possibilities for difficult-to-treat cancers.
Vivacitas Oncology is a private clinical-stage biopharmaceutical company focused on exploring innovative approaches to cancers that remain challenging to treat.
Founded in 2015, the company brings scientific and clinical perspectives together to advance research, evaluate investigational compounds and support the long-term pursuit of meaningful therapeutic progress.
Our approach examines how drug characteristics, disease biology and clinical evidence may inform future treatment research.
Investigating scientific opportunities in areas with significant unmet medical needs.
Exploring the properties of AR-67, an investigational camptothecin-derived compound.
Reviewing published early-phase research and advancing evidence-informed development decisions.
AR-67 is an investigational, lipophilic camptothecin derivative studied in early clinical research. Earlier publications and company materials describe investigations across multiple tumor types, including recurrent glioblastoma.
An oncology research program exploring the potential of a camptothecin analog.
Program Background ↗Important: AR-67 is investigational. Past study findings do not establish safety or efficacy, and orphan drug designation does not mean FDA approval. This site does not offer patient treatment, prescribing or clinical trial enrollment.
Selected historical company communications and resources. Publication dates are shown where verified; links lead to the source material.
An introduction to the investigational compound and previously reported development work.
Explore the research →Explore the archived company announcement about the Biotech Showcase investor conference.
Read announcement →Read an archived update on the company's scientific conference participation.
Read announcement →Explore the company's historical investor information and connect through published contact channels for corporate inquiries.
Interested in scientific research, company information or potential collaboration? Use the published company contact channel below.
This form opens your email application; no information is stored on this website.